Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0N7MS
|
|||
Former ID |
DIB018743
|
|||
Drug Name |
ACAA
|
|||
Synonyms |
ACA
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C21H23NO3
|
|||
Canonical SMILES |
CCCCCC1=CC=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O
|
|||
InChI |
1S/C21H23NO3/c1-2-3-4-7-16-10-12-17(13-11-16)14-15-20(23)22-19-9-6-5-8-18(19)21(24)25/h5-6,8-15H,2-4,7H2,1H3,(H,22,23)(H,24,25)/b15-14+
|
|||
InChIKey |
GAMRBCZMOOMBSQ-CCEZHUSRSA-N
|
|||
CAS Number |
CAS 99196-74-4
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:114200
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Long transient receptor potential channel 2 (TRPM2) | Target Info | Blocker (channel blocker) | [2] |
Long transient receptor potential channel 8 (TRPM8) | Target Info | Blocker (channel blocker) | [3] | |
Short transient receptor potential channel 3 (TRPC3) | Target Info | Blocker (channel blocker) | [4] | |
Short transient receptor potential channel 6 (TRPC6) | Target Info | Blocker (channel blocker) | [5] | |
KEGG Pathway | Inflammatory mediator regulation of TRP channels | |||
Panther Pathway | Alzheimer disease-presenilin pathway | |||
Pathway Interaction Database | Endothelins | |||
Nephrin/Neph1 signaling in the kidney podocyte | ||||
EPO signaling pathway | ||||
PAR1-mediated thrombin signaling events | ||||
Trk receptor signaling mediated by PI3K and PLC-gamma | ||||
Reactome | TRP channels | |||
Effects of PIP2 hydrolysis | ||||
Role of second messengers in netrin-1 signaling | ||||
WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | |||
Platelet homeostasis | ||||
Netrin-1 signaling | ||||
GPCR downstream signaling | ||||
Effects of PIP2 hydrolysis |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2443). | |||
REF 2 | Inhibition of TRPM2 cation channels by N-(p-amylcinnamoyl)anthranilic acid. Br J Pharmacol. 2006 Jun;148(3):264-73. | |||
REF 3 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 500). | |||
REF 4 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 488). | |||
REF 5 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 491). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.